resveratrol has been researched along with caprylates in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berginc, K; Gašperlin, M; Kristl, A; Seljak, KB; Trontelj, J; Zvonar, A | 1 |
| Hu, XP; Ma, XC; Shahidi, F; Tian, XG; Wang, C; Xie, HK; Yin, FW; Zhou, DY; Zhu, BW | 1 |
2 other study(ies) available for resveratrol and caprylates
| Article | Year |
|---|---|
A self-microemulsifying drug delivery system to overcome intestinal resveratrol toxicity and presystemic metabolism.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caco-2 Cells; Caprylates; Castor Oil; Chemistry, Pharmaceutical; Drug Carriers; Emulsions; Glycerides; Humans; Intestinal Absorption; Jejunum; Male; Multidrug Resistance-Associated Proteins; Permeability; Rats; Rats, Sprague-Dawley; Resveratrol; Solubility; Stilbenes; Surface-Active Agents; Technology, Pharmaceutical; Viscosity | 2014 |
Stability of resveratrol esters with caprylic acid during simulated in vitro gastrointestinal digestion.
Topics: Caprylates; Digestion; Drug Stability; Esters; Gastric Juice; Gastrointestinal Tract; Hydrolysis; Intestines; Lipase; Mouth; Oxidation-Reduction; Phospholipases A2; Resveratrol; Stomach | 2019 |